Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 32.48
-1.70 (-4.97%)
Sep 10, 2026, 11:59 AM HKT
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 828 employees as of June 30, 2026. The number of employees increased by 61 or 7.95% since the number was reported on December 31, 2025.
Employees
828
Change
61
Growth
7.95%
Revenue / Employee
896.02K HKD
Profits / Employee
-2.05M HKD
Market Cap
12.57B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 828 | 61 | 7.95% |
| Dec 31, 2025 | 767 | 200 | 35.27% |
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Everest Medicines | 812 |
| Suzhou Ribo Life Science | 453 |
| HBM Holdings | 327 |
| Duality Biotherapeutics | 231 |
| Ascletis Pharma | 202 |
| CStone Pharmaceuticals | 102 |
| LongBio Pharma (Suzhou) | 94 |
Ascentage Pharma Group International News
- 7 days ago - Ascentage Pharma to Participate in Four Upcoming Investor Conferences - GlobeNewsWire
- 20 days ago - Half Year 2026 Ascentage Pharma Group International Earnings Presentation Transcript - GuruFocus
- 20 days ago - Ascentage Pharma Group International H1 Earnings Call Highlights - MarketBeat
- 20 days ago - Ascentage Pharma Group International Earnings Call Transcript: H1 2026 - Transcripts
- 20 days ago - Ascentage Pharma Group International Earnings release: H1 2026 - Filings
- 20 days ago - Ascentage Pharma Group International Slides: H1 2026 - Filings
- 20 days ago - Ascentage Pharma Loss H1 Revenue Jumps 29%; Advances Olverembatinib And Lisaftoclax Programs - Nasdaq
- 21 days ago - Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates - GlobeNewsWire